3-[(3S,6S,9S,12S,15S,18S,21S,25R)-9-(carboxymethyl)-3,6,15-tris(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-12,18-di(propan-2-yl)-25-tridecyl-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-21-yl]propanoic acid

Term ID

CHEBI:224428

Synonyms

3-[(3S,6S,9S,12S,15S,18S,21S,25R)-9-(carboxymethyl)-3,6,15-tris(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-12,18-di(propan-2-yl)-25-tridecyl-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-21-yl]propanoic acid

Definition

References

Chemspider:78438285

Ontology

ChEBI ( EBI )

Relationships

is a type of: cyclodepsipeptide

cyclodepsipeptide Show first 5 Terms

Phenotype

Phenotype resulting from 3-[(3S,6S,9S,12S,15S,18S,21S,25R)-9-(carboxymethyl)-3,6,15-tris(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-12,18-di(propan-2-yl)-25-tridecyl-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-21-yl]propanoic acid

Phenotype where environments contain 3-[(3S,6S,9S,12S,15S,18S,21S,25R)-9-(carboxymethyl)-3,6,15-tris(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-12,18-di(propan-2-yl)-25-tridecyl-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-21-yl]propanoic acid

Phenotype modified by environments containing 3-[(3S,6S,9S,12S,15S,18S,21S,25R)-9-(carboxymethyl)-3,6,15-tris(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-12,18-di(propan-2-yl)-25-tridecyl-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-21-yl]propanoic acid

Human Disease Model